Arizona Chemical Sold to Rhone Capital As Part of International Paper Deal
22101
By Urvaksh Karkaria, The Florida Times-Union, Jacksonville  Dec. 20--International Paper said Tuesday it will sell its  Jacksonville-based Arizona Chemical business to Rhone Capital III L.P. for  $485 million, as the paper maker focuses on its uncoated paper and packaging  businesses.
77186
By Dan Wallach, The Beaumont Enterprise, Texas  Feb. 16--Huntsman Corp. intends to sell its domestic base chemicals and  polymers business, including its Port Arthur plant, to Flint Hills Resources  LLC, a wholly owned subsidiary of Koch Industries Inc. of Wichita, Kan.
715376
British insurer Royal & Sun Alliance   (RSA) said on Monday it had completed the disposal of  its U.S. operation to Arrowpoint Capital Corp., the company set  up by the unit's management, causing its shares to rise.
744492
Tokyo, June 25 (Jiji Press)--Midsize Japanese drug maker Toyama Chemical Co.  said Monday it has granted Roche Holding AG of Switzerland rights to develop and market its rheumatism drug in global markets excluding Japan.
350730
Journal Register Company (NYSE:JRC) today announced that it has  completed the sale of its two daily community newspapers and five  non-daily publications in Massachusetts to GateHouse Media, Inc.
289798
Stora Enso Oyj, one of the world's largest makers of paper products, is selling its North American unit for about $2.1 billion to an Ohio-based company owned by the private equity firm Cerberus Capital.
150721
Albatros Plant Nutrition, which was part of the McDonogh group, has been sold to Timac Agri business, a subsidiary of the French fertilizer company Roullier.
722341
German drugs and chemicals group  Bayer  said it planned to sell unit H.C. Starck to a  consortium formed by Advent International and the Carlyle Group  for 700 million euros ($908 million) plus debt.
737404
Hexion Specialty Chemicals, the world's  leading global source for thermoset resins, announced today that it has  reached a definitive agreement to acquire the German resins and  formaldehyde business of ARKEMA GmbH.  Terms of the agreement were not disclosed.
110719
German drugmaker Merck MRCG.DE on   Thursday agreed to buy a 64.5 percent stake in rival Serono   SEO.VX in a surprise deal valued over 10 billion Swiss francs   ($8.3 billion), creating a new force in European   pharmaceuticals.
12330
By David Robinson, The Buffalo News, N.Y.  Jun. 20--Isochem Inc. has been acquired by a New York City leveraged buyout firm Buckingham Capital Partners, which plans to run the Lockport chemical company under its original name, VanDeMark Chemical.
106714
By Chattanooga Times/Free Press, Tenn.  Jun. 20--Sunshine Holdings Corp. of Arizona has completed the merger of its Sunshine Custom Publishing Inc. division with True North Custom Publishing LLC of Chattanooga.
671555
International Paper Co., the world&#39;s largest forest products company, has agreed to sell all of the 1.1 million acres of woodlands it owns in Maine and New Hampshire to GMO Renewable Resources LLC for $250 million.
462497
By Christopher Hope, Business Correspondent, and Harry Wallop (Filed: 22/11/2004). Phoenix Venture Holdings, the owner of loss-making MG Rover, has sold off the last remaining major piece of land at its Longbridge
267808
Germany's Schwarz Pharma SRZG.DE   said on Monday it had agreed to be bought by Belgium's UCB   UCBBt.BR for around $5.6 billion in shares and cash in the   third major drug sector transaction in Germany in five days.
221563
UCB, a Belgian drug maker, said it had agreed to buy Schwarz Pharma of Germany for 4.4 billion euros ($5.6 billion) to gain experimental medicines for ParkinsonÂs disease, epilepsy and bladder control. Schwarz investors will get 91.10 euros a share in cash and stock, 20 percent more than the closing price on Friday, UCB said. The Schwarz-Schuette family, which owns 60 percent of the company, backed the offer. Schwarz, based in Monheim, Germany, is the third European family-owned drug maker to sell in less than a week as the cost of developing new products rises. UCB, which faces patent expirations on its top sellers starting next year, will get three drugs that may provide more than 2 billion euros in annual revenue.
481065
UK general insurer Royal & Sun Alliance   Insurance Group Plc RSA.L said on Thursday it was selling its   U.S. arm to Arrowpoint Capital, providing the company with a   long-awaited exit from its U.S. unit.